Emerald Advisers, LLC Neogenomics Inc Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,682,214 shares of NEO stock, worth $27.6 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
1,682,214
Previous 1,844,615 8.8%
Holding current value
$27.6 Million
Previous $25.6 Million 3.02%
% of portfolio
1.03%
Previous 1.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$13.4 - $17.73 $2.18 Million - $2.88 Million
-162,401 Reduced 8.8%
1,682,214 $24.8 Million
Q2 2024

Aug 06, 2024
SELL
$13.01 - $15.77 $797,369 - $966,527
-61,289 Reduced 3.22%
1,844,615 $25.6 Million
Q1 2024

May 08, 2024
BUY
$14.06 - $16.79 $113,745 - $135,831
8,090 Added 0.43%
1,905,904 $30 Million
Q4 2023

Feb 05, 2024
SELL
$11.67 - $20.73 $341,464 - $606,559
-29,260 Reduced 1.52%
1,897,814 $30.7 Million
Q3 2023

Oct 26, 2023
BUY
$12.15 - $17.85 $3.29 Million - $4.83 Million
270,855 Added 16.35%
1,927,074 $23.7 Million
Q2 2023

Jul 25, 2023
SELL
$14.1 - $19.83 $184,780 - $259,872
-13,105 Reduced 0.79%
1,656,219 $26.6 Million
Q1 2023

May 04, 2023
SELL
$9.09 - $19.45 $3.93 Million - $8.41 Million
-432,243 Reduced 20.57%
1,669,324 $29.1 Million
Q4 2022

Feb 03, 2023
SELL
$6.45 - $12.07 $245,177 - $458,804
-38,012 Reduced 1.78%
2,101,567 $19.4 Million
Q3 2022

Oct 25, 2022
BUY
$7.86 - $12.91 $7.28 Million - $12 Million
926,226 Added 76.34%
2,139,579 $18.4 Million
Q2 2022

Jul 29, 2022
BUY
$7.06 - $13.97 $863,021 - $1.71 Million
122,241 Added 11.2%
1,213,353 $9.89 Million
Q1 2022

Apr 29, 2022
BUY
$12.15 - $35.28 $2.5 Million - $7.26 Million
205,676 Added 23.23%
1,091,112 $13.3 Million
Q4 2021

Feb 02, 2022
SELL
$30.49 - $48.49 $575,102 - $914,618
-18,862 Reduced 2.09%
885,436 $30.2 Million
Q3 2021

Oct 28, 2021
BUY
$41.66 - $52.52 $1.34 Million - $1.7 Million
32,276 Added 3.7%
904,298 $43.6 Million
Q2 2021

Jul 29, 2021
SELL
$36.62 - $51.69 $11.4 Million - $16 Million
-310,360 Reduced 26.25%
872,022 $39.4 Million
Q1 2021

Apr 29, 2021
SELL
$41.56 - $59.88 $7 Million - $10.1 Million
-168,423 Reduced 12.47%
1,182,382 $57 Million
Q4 2020

Jan 29, 2021
SELL
$36.08 - $56.47 $525,000 - $821,694
-14,551 Reduced 1.07%
1,350,805 $72.7 Million
Q3 2020

Oct 28, 2020
SELL
$33.26 - $40.48 $2 Million - $2.44 Million
-60,199 Reduced 4.22%
1,365,356 $50.4 Million
Q2 2020

Jul 28, 2020
BUY
$24.21 - $31.02 $2.48 Million - $3.17 Million
102,257 Added 7.73%
1,425,555 $44.2 Million
Q1 2020

Apr 30, 2020
SELL
$20.5 - $34.53 $3.47 Million - $5.85 Million
-169,301 Reduced 11.34%
1,323,298 $36.5 Million
Q4 2019

Jan 29, 2020
SELL
$18.96 - $29.84 $4.65 Million - $7.32 Million
-245,220 Reduced 14.11%
1,492,599 $43.7 Million
Q3 2019

Oct 31, 2019
SELL
$19.12 - $26.24 $4.08 Million - $5.6 Million
-213,242 Reduced 10.93%
1,737,819 $33.2 Million
Q2 2019

Jul 31, 2019
BUY
$19.57 - $24.1 $1.41 Million - $1.74 Million
72,160 Added 3.84%
1,951,061 $42.8 Million
Q1 2019

May 01, 2019
SELL
$12.14 - $20.46 $362,913 - $611,631
-29,894 Reduced 1.57%
1,878,901 $38.4 Million
Q4 2018

Jan 30, 2019
BUY
$11.24 - $18.5 $2.66 Million - $4.38 Million
236,965 Added 14.17%
1,908,795 $24.1 Million
Q3 2018

Oct 31, 2018
BUY
$12.5 - $15.38 $3.72 Million - $4.57 Million
297,384 Added 21.64%
1,671,830 $25.7 Million
Q2 2018

Jul 31, 2018
BUY
$7.99 - $14.05 $870,103 - $1.53 Million
108,899 Added 8.6%
1,374,446 $18 Million
Q1 2018

Apr 26, 2018
SELL
$7.23 - $8.76 $1.15 Million - $1.39 Million
-158,716 Reduced 11.14%
1,265,547 $10.3 Million
Q4 2017

Feb 05, 2018
BUY
$8.02 - $11.18 $343,175 - $478,392
42,790 Added 3.1%
1,424,263 $12.6 Million
Q3 2017

Oct 30, 2017
BUY
$9.11 - $11.26 $12.6 Million - $15.6 Million
1,381,473
1,381,473 $15.4 Million

Others Institutions Holding NEO

# of Institutions
294
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.06B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email